Optiscan has developed a second commercial product using our unique endo-microscope technology for the pre-clinical research market.
This product is the Optiscan FIVE 1 endo-microscope, FIVE being an anagram of Fluorescent In Vivo Endo-microscope.
Our analysis of target markets has revealed strong interest from two customer groups. One is drug companies conducting pre-clinical analysis of new drug therapies and the other is doctors wanting to complete research spanning both clinical and pre-clinical settings.
We are confident that ease of use and ability to do high resolution in-vivo imaging will enable Optiscan FIVE 1 customers to improve the content and quality of their pre-clinical research programs.
Design and development expenditure on the Optiscan FIVE 1 is now complete. The instrument packages the same miniaturised scanner as Optiscan supplies for flexible endoscopes into a small rigid endoscope style probe. This then connects to a CIS sub-system which has small but important variations in configuration and software from the model produced for Pentax. Regulatory clearances prevent it being used in clinical practice.
The sales process being adopted is a direct sales model into core markets using major exhibitions and congresses, reinforced with journal publications to reach customers and create product awareness. Sales leads have been strong and several quotations have been issued.
The market size for these pre-clinical research instruments is significantly smaller than for medical markets. However, carrying our own brand on the instrument creates significantly greater margin opportunity. We therefore view the Optiscan FIVE 1 as an adjunct commercial opportunity.
Click here for Optiscan FIVE 1 product information
